Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alexander's

201.85
+3.001.51%
Post-market: 201.850.00000.00%19:56 EDT
Volume:9.77K
Turnover:1.96M
Market Cap:1.03B
PE:23.86
High:202.50
Open:199.53
Low:199.53
Close:198.85
Loading ...

New York REIT Alexander's Posts Decline in 4Q Profit, Revenue

Dow Jones
·
10 Feb

Alexander's Q4 Adjusted FFO, Revenue Decline

MT Newswires Live
·
10 Feb

BRIEF-Alexander's Q4 Adjusted FFO Per Share USD 4.06

Reuters
·
10 Feb

Alexander's Q4 Adjusted Ffo USD 20.845 Million

THOMSON REUTERS
·
10 Feb

Alexander's Q4 Basic EPS USD 2.39

THOMSON REUTERS
·
10 Feb

Alexander's Q4 Adjusted Ffo per Share USD 4.06

THOMSON REUTERS
·
10 Feb

Alexander’s Announces Fourth Quarter Financial Results

GlobeNewswire
·
10 Feb

Alexander's Q4 FFO $4.06 Beats $3.71 Estimate, Sales $55.91M Beat $55.20M Estimate

Benzinga
·
10 Feb

Alexander's Inc expected to post a share - Earnings Preview

Reuters
·
07 Feb

Alexander's Maintains Quarterly Dividend at $4.50 Per Share; Payable Feb. 28 to Shareholders of Record on Feb. 18

MT Newswires Live
·
06 Feb

Alexander’s Declares Quarterly $4.50 Dividend on Common Shares

GlobeNewswire
·
06 Feb

UBS Cuts Price Target on ALX Oncology Holdings to $2.20 From $4, Keeps Buy Rating

MT Newswires Live
·
27 Jan

Alexander’s, Inc. (ALX): Why You Should Invest In This Extreme Dividend Stock Now

Insider Monkey
·
26 Jan

ALX Oncology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
24 Jan

Promising Phase 2 ASPEN-06 Study Positions ALX Oncology’s Evorpacept as a Strong Contender in HER2+ Gastric Cancer Treatment

TIPRANKS
·
24 Jan

ALX Oncology price target lowered to $5 from $25 at H.C. Wainwright

TIPRANKS
·
24 Jan

ALX Oncology Shares Drop 15% Following Positive Phase 2

GuruFocus.com
·
24 Jan

ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer

GlobeNewswire
·
23 Jan

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

GlobeNewswire
·
23 Jan

ALX Oncology Names New CFO; Shares Rise

MT Newswires Live
·
23 Jan